SEC Form 10-K filed by DuPont de Nemours Inc.

Directors bring strong mix of industry expertise, diverse leadership experience and perspectives WILMINGTON, Del., March 26, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the members of the future board of directors (the "Electronics Board") for the independent Electronics public company that will be created following its intended spin-off from DuPont. The Electronics Board is expected to consist of nine members following the completion of the separation, which is targeted for November 1, 2025. "As we prepare the Electronics business to become an independent public com

SHANGHAI, March 24, 2025 /PRNewswire/ -- DuPont will showcase how we are shaping the next generation of electronics at the International Electronic Circuits (Shanghai) Exhibition 2025. With a diverse portfolio of advanced circuit materials and solutions designed to push the limits of fine-line technology, signal integrity, and thermal management, DuPont will be exhibiting in Booth #8A31 at National Exhibition and Convention Center (NECC) from March 24-26. "As artificial intelligence (AI), machine learning, and 5G technologies continue to advance, the demand for high-performanc

Intended spin-off of Electronics remains on track for November 1, 2025, completion WILMINGTON, Del., March 17, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced Jon Kemp, President, DuPont Electronics & Industrial will be the Chief Executive Officer and a member of the board of directors for the future independent Electronics public company that will be created following its intended spin-off from DuPont. As a focused independent company, Electronics will be a global leader in materials and technology solutions for the semiconductor and electronics industries. "Jon is a gr

Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously

Wolfe Research upgraded DuPont from Peer Perform to Outperform and set a new price target of $91.00

Barclays downgraded DuPont from Equal Weight to Underweight and set a new price target of $84.00 from $88.00 previously

4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

10-K - DuPont de Nemours, Inc. (0001666700) (Filer)

WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock (par value $0.01 per share), representing an 8% increase to its 2024 quarterly dividends, payable on March 17, 2025, to holders of record of said stock at the close of business on March 3, 2025.(1) (1) Future dividends are at the discretion of the DuPont Board of Directors. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and s

Fourth Quarter 2024 Highlights Net Sales of $3.1 billion increased 7%; organic sales increased 7% versus year-ago periodGAAP Loss from continuing operations of $(61) million, operating EBITDA of $807 millionGAAP EPS from continuing operations of $(0.17); adjusted EPS of $1.13Cash provided by operating activities from continuing operations of $564 million; transaction-adjusted free cash flow of $455 millionFull Year 2024 Highlights Net Sales of $12.4 billion increased 3%; organic sales increased 1% versus prior yearGAAP Income from continuing operations of $778 million; operating EBITDA of $3.14 billionGAAP EPS from continuing operations of $1.77; adjusted EPS of $4.07Cash provided by operati

WILMINGTON, Del., Jan. 15, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its fourth quarter and full year 2024 financial results at 6:00 a.m. ET on Tuesday, February 11, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.        The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference

SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)